Risk factors associated with <i><scp>C</scp>lostridium difficile</i> infection after kidney and pancreas transplantation

Abstract

Careful antimicrobial selection and assurance of optimal treatment duration in the kidney and pancreas transplant population is prudent. Clinicians should have a heightened awareness of CDI risk particularly during periods of leukopenia and in the setting of gastrointestinal procedures.